Quick Takeaways
- BB BIOTECH AG filed SCHEDULE 13G/A for Agios Pharmaceuticals, Inc. Common Stock (AGIO).
- Disclosed ownership: 0%.
- Date of event: 01 Jun 2025.
BB BIOTECH AG - 01 Jun 2025 SCHEDULE 13G/A Report for Agios Pharmaceuticals, Inc. Common Stock (AGIO)
- Filing Manager
- BB BIOTECH AG
- Reporting Manager
- BB Biotech AG
- Symbol
- AGIO
- Disclosed Ownership
- 0 shares
- Ownership
- 0%
- Form type
- SCHEDULE 13G/A
- Filing time
- 13 Jun 2025, 14:50:40 UTC
- Date of event
- 01 Jun 2025
- Previous filing
- 14 Feb 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"BB BIOTECH AG disclosed 0% ownership in Agios Pharmaceuticals, Inc. Common Stock (AGIO) on 01 Jun 2025."
What Changed
- Previous schedule filing date: 14 Feb 2025.
- Current filing was accepted on 13 Jun 2025, 14:50.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (2)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| BB Biotech AG | 0% | 0 | 0 | 0 | /s/ Christian Koch | Christian Koch/Signatory Authority | |
| Biotech Target N.V. | 0% | 0 | 0 | 0 | /s/ Jan Bootsma | Jan Bootsma/Signatory Authority |